Skip to main content
Clinical Trials/DRKS00023983
DRKS00023983
Not yet recruiting
未知

Efficacy and acceptability of interval fasting in cardiac rehabilitation - a randomized controlled trial - InterVfast

refonet Rehabilitations-Forschungsnetzwerk der Deutschen Rentenversicherung Rheinland0 sites100 target enrollmentFebruary 17, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
I20-I25
Sponsor
refonet Rehabilitations-Forschungsnetzwerk der Deutschen Rentenversicherung Rheinland
Enrollment
100
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
refonet Rehabilitations-Forschungsnetzwerk der Deutschen Rentenversicherung Rheinland

Eligibility Criteria

Inclusion Criteria

  • BMI between 28 and 35 kg/m2

Exclusion Criteria

  • Excludes patients with addictive disorders, eating disorders, liver cirrhosis, renal insufficiency grade 4 or higher, severe obesity (BMI \> 35 kg/m2\), oncologic diseases, gastric/duodenal ulcers, or language impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials